Evalytica(TM) contains a growing repository of pre-built Analysis Apps that provide extensive analytic capabilities in areas such as drug safety, epidemiology, health economics, and comparative effectiveness, along with a programming interface for custom Analytic App development. Collaboration features, such as a library of reusable patient cohort and health outcome definitions that can be curated, searched, shared and re-used across users and analysis communities, foster collaboration and sharing based on an area of common interest, such as therapeutic area, pharmaceutical product, or research project.
Designed by a team of industry pioneers, Evalytica(TM) builds upon the strengths of previous real-world analytics technologies while also addressing their weaknesses. "Being able to draw upon one of the most well-respected research teams in the life sciences industry has been a tremendous advantage for us in developing Evalytica(TM)," said Stephanie Reisinger, Vice President of Technology Solutions, Evidera. "Evalytica(TM) provides an option for users to connect directly with Evidera scientists to get help with database selection, cohort definition, analysis methodology, results interpretation or any other question associated with an analysis."
To schedule a demo of Evalytica(TM), or for more information, please visit www.evalytica.com .
About Evidera
Evidera, a wholly owned subsidiary of Symphony Technology Group , provides health economic, outcomes research, market access, data analytic and epidemiology services to life sciences organizations worldwide. For more information, visit www.evidera.com .
Media Contact
Susan Potter Couch, Director, Marketing & Communications
Susan.Couch@evidera.com
+1 681 252 3342
PRNewswire
